Table 2 Overview of recent treatment patterns of gout in the USA
From: Gout. Novel therapies for treatment of gout and hyperuricemia
Total ambulatory visits, and visits to primary care versus specialists | Â |
   Total number of ambulatory care visits | 973 million |
   Number of visits for gout | 3.9 million (0.4% of total) |
   Percentage of total visits for gout to: |  |
Primary care | 69% |
Cardiologists | 10% |
'Other specialists or unknown' | <16% |
Rheumatologists | <2% |
Number of gout patient-specific anti-inflammatory prescriptions (absolute number of prescriptions/year) | Â |
   Colchicine | ~381,000 |
   NSAIDs | ~700,000 |
   Prednisone | ~341,000 |
Number of gout patient-specific urate-lowering prescriptions (absolute number of prescriptions/year) | Â |
   Allopurinol | 2.8 million |
   Probenecid | 8,000 |
Demographics of allopurinol prescribing: percentage of gout patients that are: | Â |
   Caucasian | 80% |
   African Americans | 49% |
   Asians | 19% |